Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
Johansson
S
S
Department of Oncology, Karolinska Hospital, Stockholm, Sweden.
Steineck
G
G
Hursti
T
T
Fredrikson
M
M
Fürst
C J
CJ
Peterson
C
C
D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001712:Biperiden / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008140:Lorazepam / Q000627:therapeutic use; D008558:Melphalan / Q000008:administration & dosage; D008787:Metoclopramide / Q000627:therapeutic use; D008875:Middle Aged; D017294:Ondansetron; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D007093:Imidazoles; D001712:Biperiden; D017294:Ondansetron; D003907:Dexamethasone; D004317:Doxorubicin; D008787:Metoclopramide; D008140:Lorazepam; D002945:Cisplatin; D008558:Melphalan